24-Hydroxylase Deficiency and CYP24A1 Mutation Patient Registry

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT03478761
Status
Recruiting

Conditions

  • 24-hydroxylase Deficiency

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

You are being asked to take part in this research registry because you or your family member is suspected to have a 24-hydroxylase deficiency.

Key Dates

Start date
Oct 19, 2017
Status verified
Mar 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
600 participants (estimated)

Primary Outcome Measure

establish and maintain a registry of suspected and confirmed patients with 24 hydroxylase deficiency [ Time Frame: yearly ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905
Barbara M Seide, CCRP
800-270-4637
Carly Banks, CCRP
800-270-4637

Find similar trials in Rochester, MN